Die Rehabilitation, Inhaltsverzeichnis Rehabilitation (Stuttg) 2019; 58(01): 12-14DOI: 10.1055/a-0810-3856 Der interessante Fall © Georg Thieme Verlag KG Stuttgart · New York Herausfordernde Blutzuckereinstellung bei einer frisch lebertransplantierten Diabetikerin in der Anschlussrehabilitation Artikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 United Network for Organ Sharing. Transplants by Organ Type Richmond VA USA. https://www.unos.org/data/ transplant-trends/.Stand: 21.09.2018 2 Das Statistik Portal https://de.statista.com/statistik/daten/studien/226634/umfrage/anzahl Stand: 14.09.2018 3 Stepanova M, Wai H, Saab S. et al. The outcomes of adult liver transplants in the United States for 1987 to 2013. Liver Int 2015; 35: 2036-2041 4 Abbasoglou O, Levy M, Brkic BB. et al. Ten years of liver transplantation. Transplantation 1997; 64: 1861-1867 5 Deutsche Stiftung Organtransplantation (DSO). Jahresbericht. 2014 6 Kuo HT, Sampaio MS, Ye X. et al. Risk factors for new onset diabetes mellitus in adult liver transplantrecipeints, an analysis of the organ procurement and transplant network/united network for organ sharing database. Transplantation 2010; 89: 1134-1140 7 Temur H, Müller M, Oehler G. Prävalenz von Kohlenhydratintoleranz und Diabetes mellitus bei Patienten nach Lebertransplantation-Möglicher Einfluss der Ernährung und der Pharmakotherapie. Z Gastroenterol 43: P444 8 Pelaez-Jaramillo MJ, Cardenas-Moija AA, Gaete PV. et al. Post liver transplantation diabetes mellitus. A review of relevance and approach to treatment. Diabetes Therapy 2018; 9: 521-541 9 Hayden G, Neuberger J. Liver transplantation in cirrhotic patients with diabetes mellitus. Liver Transplantation 2001; 7: 234-237 10 Trail KC, Stratta RJ, Larsen JL. et al. Results of liver transplantation in diabetic recipients. Surgery 1993; 114: 650-65411 11 Nationale Versorgungsleitlinien. Therapie des Typ-2-Diabtes, Version 4. August 2013, geändert November 2014; 12 Hum J, Jou J, Green PK. et al. Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus. Diabetes Care 2017; 40: 1173-1180 13 Ohanasekaran R. Management of immunosuppression in liver transplantation. Clin Liver Dis 2017; 21: 337-351 14 Ozbay LA, Smidt K, Mortensen DM. et al. Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-16 betacells. Br J Pharmacol 2011; 162: 136-146 15 Vankiatamanamanam R. et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokin 1995; 29: 404-430 16 Hübner GI, Eismann R, Sziegoleit W. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplan patients. Ther Drug Monit 1999; 21: 536-539 17 Montero N, Pascual J. Immunosuppression and post-transplant hyperglycemia. Curr Diabetes Rev 2015; 11: 144-154
